• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,139
109
75
71
68

COUNTRY

70
22
16
10
9

CATEGORIES

  • 574
  • 118
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

879
1,165
1,601
2,946

PUBLISHED

152
222
686
2,946

PRODUCT TYPE

2,375
494
67
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides - Product Thumbnail Image

Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific...

January 2013
FROM
Triple Analysis: Colorectal Cancer, Angiogenesis and Peptides Triple Analysis: Colorectal Cancer, Angiogenesis and Peptides - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Angiogenesis and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area...

January 2013
FROM
Triple Analysis: Leukemia, Lymphoma and Peptides Triple Analysis: Leukemia, Lymphoma and Peptides - Product Thumbnail Image

Triple Analysis: Leukemia, Lymphoma and Peptides

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...

January 2013
FROM
Triple Analysis: Lung Cancer, Angiogenesis and Peptides Triple Analysis: Lung Cancer, Angiogenesis and Peptides - Product Thumbnail Image

Triple Analysis: Lung Cancer, Angiogenesis and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides)....

January 2013
FROM
Triple Analysis: Lymphoma, Apoptosis and Peptides Triple Analysis: Lymphoma, Apoptosis and Peptides - Product Thumbnail Image

Triple Analysis: Lymphoma, Apoptosis and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides)....

January 2013
FROM
Triple Analysis: Prostate Cancer, Angiogenesis and Peptides Triple Analysis: Prostate Cancer, Angiogenesis and Peptides - Product Thumbnail Image

Triple Analysis: Prostate Cancer, Angiogenesis and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area...

January 2013
FROM
Triple Analysis: Breast Cancer, Lung Cancer and Peptides Triple Analysis: Breast Cancer, Lung Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Breast Cancer, Lung Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...

January 2013
FROM
Triple Analysis: Colorectal Cancer, Lung Cancer and Peptides Triple Analysis: Colorectal Cancer, Lung Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Lung Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated...

January 2013
FROM
Triple Analysis: Leukemia, Prostate Cancer and Peptides Triple Analysis: Leukemia, Prostate Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Leukemia, Prostate Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Leukemia and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...

January 2013
FROM
Triple Analysis: Leukemia, Antibodies and Peptides Triple Analysis: Leukemia, Antibodies and Peptides - Product Thumbnail Image

Triple Analysis: Leukemia, Antibodies and Peptides

This triple analysis focuses on cancer drug development strategies in Leukemia and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according...

January 2013
FROM
Triple Analysis: Lymphoma, Prostate Cancer and Peptides Triple Analysis: Lymphoma, Prostate Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Lymphoma, Prostate Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...

January 2013
FROM
Triple Analysis: Breast Cancer, Angiogenesis and Peptides Triple Analysis: Breast Cancer, Angiogenesis and Peptides - Product Thumbnail Image

Triple Analysis: Breast Cancer, Angiogenesis and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides)....

January 2013
FROM
Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated...

January 2013
FROM
Triple Analysis: Leukemia, Lung Cancer and Peptides Triple Analysis: Leukemia, Lung Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Leukemia, Lung Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...

January 2013
FROM
Triple Analysis: Lung Cancer, Prostate Cancer and Peptides Triple Analysis: Lung Cancer, Prostate Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Lung Cancer, Prostate Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated...

January 2013
FROM
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides - Product Thumbnail Image

Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific...

January 2013
FROM
Triple Analysis: Pancreatic Cancer, Antibodies and Peptides Triple Analysis: Pancreatic Cancer, Antibodies and Peptides - Product Thumbnail Image

Triple Analysis: Pancreatic Cancer, Antibodies and Peptides

This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated...

January 2013
FROM
Triple Analysis: Breast Cancer, Antibodies and Peptides Triple Analysis: Breast Cancer, Antibodies and Peptides - Product Thumbnail Image

Triple Analysis: Breast Cancer, Antibodies and Peptides

This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according...

January 2013
FROM
Triple Analysis: Colorectal Cancer, Antibodies and Peptides Triple Analysis: Colorectal Cancer, Antibodies and Peptides - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Antibodies and Peptides

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated...

January 2013
FROM
Triple Analysis: Leukemia, Pancreatic Cancer and Peptides Triple Analysis: Leukemia, Pancreatic Cancer and Peptides - Product Thumbnail Image

Triple Analysis: Leukemia, Pancreatic Cancer and Peptides

This triple analysis focuses on cancer drug development strategies in both Leukemia and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated...

January 2013
FROM
Loading Indicator

Our Clients

Our clients' logos